Association between serum lactate dehydrogenase and cutaneous immune-related adverse events among patients on immune checkpoint inhibitors for advanced melanoma - 14/10/22
Key words : cutaneous immune-related adverse events, dermatologic toxicities, immune checkpoint inhibitor, immune-related adverse events, immunotherapy, melanoma, serum LDH, tumor burden
Authors Asdourian and Otto contributed equally to this work. |
|
Funding Sources: STC is supported by a Medical Dermatology Career Development Award from the Dermatology Foundation. |
|
IRB Approval Status: Approved by the Mass General Brigham IRB (Protocol No. 2017P000501). |
Vol 87 - N° 5
P. 1147-1149 - novembre 2022 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?